Bain Capital Specialty Finance BCSF
$10.37 −$0.07 (-0.67%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.37 0.00%
Open$10.37
Prev close$10.44
Day range$10.35 – $10.53
Volume585.6K
Market cap$672.69M
P/E (TTM)10.8
Dividend yield16.20%
BCSF Stock News
Headlines matching Bain Capital Specialty Finance or the BCSF ticker, most recent first.
- Lucid Capital Initiates Bain Capital Specialty Finance(BCSF.US) With Hold Rating, Announces Target Price $12.5
- BofA Securities Maintains Bain Capital Specialty Finance(BCSF.US) With Hold Rating, Maintains Target Price $13
- KBW Downgrades Bain Capital Specialty Finance(BCSF.US) to Hold Rating, Cuts Target Price to $13 Negative
- KBW Maintains Bain Capital Specialty Finance(BCSF.US) With Hold Rating, Maintains Target Price $13
- KBW Maintains Bain Capital Specialty Finance(BCSF.US) With Buy Rating, Maintains Target Price $15
- BofA Securities Maintains Bain Capital Specialty Finance(BCSF.US) With Hold Rating, Raises Target Price to $13.5 Positive
- Analysts Offer Insights on Financial Companies: Bain Capital Specialty Finance (BCSF) and Skyward Specialty Insurance Group, Inc. (SKWD)
- BofA Securities Maintains Bain Capital Specialty Finance(BCSF.US) With Hold Rating, Cuts Target Price to $13 Negative
- Wells Fargo Downgrades Bain Capital Specialty Finance(BCSF.US) to Hold Rating, Cuts Target Price to $13 Negative
- Lucid Capital Maintains Bain Capital Specialty Finance(BCSF.US) With Hold Rating, Cuts Target Price to $12 Negative
- KBW Maintains Bain Capital Specialty Finance(BCSF.US) With Hold Rating, Maintains Target Price $13
- Wells Fargo Maintains Bain Capital Specialty Finance(BCSF.US) With Hold Rating, Cuts Target Price to $11 Negative
- Wells Fargo Maintains Bain Capital Specialty Finance(BCSF.US) With Buy Rating, Maintains Target Price $16
- BofA Securities Maintains Bain Capital Specialty Finance(BCSF.US) With Hold Rating
- Bain Capital Specialty Finance: Bain Capital Specialty Finance Inc. - Cash Distribution Option Symbol: BCSF
No comments yet — be the first to weigh in on BCSF.
Sign in to join the discussion.